Vedanta Biosciences
PrivateLast Round
Financing
Apr 25, 2023
Total Funding Raised
$207M
Company Overview
Vedanta Biosciences is a biotechnology company that develops immunotherapies aimed at treating immune-mediated and infectious diseases through the use of proprietary datasets and rationally defined bacterial consortia in powder form for effective oral therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vedanta Biosciences Comps
Public and private peers based on sector, stage, and business model.
Vedanta Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Financing | Apr 25, 2023 | ||||
| Series D | Jul 21, 2021 | ||||
| Grant | Sep 30, 2020 | ||||
| Series C Extension | Sep 23, 2019 | ||||
| Series C Extension | May 13, 2019 | ||||
Series C | Dec 24, 2018 |
Key People
Founding team and executive leadership
Vedanta Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Investment | Series C Extension |
| SymBiosis Capital Management | Series D, Series C Extension |
| Health for Life Capital | Series D, VC Round |
| Administration for Strategic Preparedness and Response | Grant |
| OppenheimerFunds | Series C Extension, Series C, VC Round |
| Skyviews Life Science | Series D, Financing |
| Magnetar Capital | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Lead asset VE303 enters Phase 3 trial for C. difficile infection.
- Aug 13, 2025
24 employees impacted due to manufacturing needs.
Vedanta Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vedanta Biosciences's valuation, stock price, and market status.
